Actinium Pharmaceuticals (ATNM) Capital Leases (2018 - 2025)
Actinium Pharmaceuticals (ATNM) posted quarterly Capital Leases of $2000.0 for Q3 2025, down 83.33% year-over-year from $12000.0 in Q3 2024, and down 60.0% quarter-over-quarter from $5000.0 in Q2 2025.
Actinium Pharmaceuticals (ATNM) Capital Leases (2018 - 2025) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Capital Leases for 6 consecutive years, with $2000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Capital Leases fell 83.33% year-over-year to $2000.0; the TTM figure through Sep 2025 stood at $2000.0 (down 83.33% YoY), while the FY2024 annual figure was $9000.0, down 52.63% from the prior year.
- Capital Leases fell to $2000.0 in Q3 2025 per ATNM's latest filing, from $5000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $2.3 million in Q2 2022 and bottomed at $1000.0 in Q3 2022.
- Historically, Capital Leases has averaged $220363.6 across 5 years, with a median of $9000.0 in 2024.
- Annual changes were most pronounced in 2024 — Capital Leases tumbled 52.63% — and 2025, when it slumped 83.33%.
- Actinium Pharmaceuticals' Capital Leases stood at $3000.0 in 2021, then slumped by 66.67% to $1000.0 in 2022, then surged by 1800.0% to $19000.0 in 2023, then tumbled by 52.63% to $9000.0 in 2024, then tumbled by 77.78% to $2000.0 in 2025.
- Business Quant data shows ATNM's Capital Leases at $2000.0 in Q3 2025, $5000.0 in Q2 2025, and $7000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 2.34 Mn |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2018 | 13,354.00 |